Skip to content

Hepion Pharmaceuticals, Inc.

CTRVP HEPA

CIK 0001583771 · Pharmaceutical Preparations · OTC, OTC

  • ContraVir Pharmaceuticals, Inc. (until 2019-07-23)
← back to feed
Revenue (TTM)
$0
Q1 May 2026
Net Income (TTM)
−$8.43M
+37.3% YoY Q1 May 2026
EPS Diluted (TTM)
−$2.35
+99.2% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$12.45M
Q1 May 2026
Cash
$13.92M
Q1 May 2026
Total Debt
$832.9K
Q1 May 2026
Shares Outstanding
29.12M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings